Sequenom Inc. Completes Acquisition of CLIA-Certified Laboratory

Published: Nov 17, 2008

SAN DIEGO--(BUSINESS WIRE)--Sequenom (NASDAQ: SQNM) today announced that it has completed the previously announced acquisition of Grand Rapids, Michigan-based Center for Molecular Medicine, a Clinical Laboratory Improvement Act (CLIA) certified clinical diagnostics laboratory. As part of the acquisition, Sequenom has formalized certain collaborative agreements with Spectrum Health and the Van Andel Research Institute, which were joint venture partners in the CLIA laboratory. The CLIA laboratory has been renamed to the Sequenom Center for Molecular Medicine (SCMM).

Back to news